Loading...
$2.1M
Awarded Apr 8, 2026
Competition
FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
Offers
1
Set-Aside
SMALL BUSINESS SET ASIDE - TOTAL
Solicitation Type
RFP - Negotiated
Performance Timeline
Start
Apr 8, 2026
Estimated start: Jan 9, 2028
Contract: 140D0426C0062
UEI
N5FFBMLQHAJ9
Parent Company
OPTOSURGICAL, LLC
Capabilities & Certifications
Headquarters Location
Congressional District: 03
Current Obligation
$2,095,748
Base + Exercised Options
$2,095,748
Total Ceiling Value
$2,095,748
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
Description
SBIR PH II "TRANSLATION OF NOVEL BILIARY TRACT-SPECIFIC CONTRAST AGENT TO MEDIATE SUCCESSFUL IMAGE-GUIDED HEPATOBILIARY INTERVENTIONS"
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Place of Performance
Congressional District: 03
Awarding Agency
Top-tier Agency
Departmental Offices
Sub-tier Agency
IBC ACQ SVCS DIRECTORATE (00004)
Office
Funding Agency
Top-tier Agency
National Institutes of Health
Sub-tier Agency
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Office